Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations
- 31 March 2001
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 86 (3), 337-342
- https://doi.org/10.1016/s1081-1206(10)63310-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tree‐pollen allergy is efficiently treated by short‐term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensAllergy, 1998
- Role of interleukin 10 in specific immunotherapy.JCI Insight, 1998
- Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.The Journal of Experimental Medicine, 1993
- Clinical and immunological effects of immunotherapy with alum‐absorbed grass allergoid in grass‐pollen‐induced hay feverAllergy, 1992
- Double-blind placebo-controlled immunotherapy with mixed grass-pollen allergoidsJournal of Allergy and Clinical Immunology, 1988
- Immunological changes associated with a successful outcome of pollen immunotherapyAllergy, 1988
- Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extractJournal of Allergy and Clinical Immunology, 1987
- High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergensClinical and Experimental Allergy, 1987
- Grass pollen immunotherapy: A single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitisJournal of Allergy and Clinical Immunology, 1984
- Immunologic and cellular changes accompanying the therapy of pollen allergyJCI Insight, 1971